Skip to main content
Free shipping on all orders
888-559-3802
Go back
VitabaseIngredients

Calyptridium umbellatum

Table of contents

Other Names

alpine cistantheCalyptridium umbellatum var. caudiciferumCalyptridium umbellatum var. caudiciferum (A. Gray) Jeps.Calyptridium umbellatum var. umbellatumCistanthe umbellataCistanthe umbellata (Torr.) Hershk.Cistanthe umbellata var. caudiciferaCistanthe umbellata var. caudicifera (A. Gray) Kartesz & GandhiCistanthe umbellata var. umbellataMount Hood pussypawspussy-pawspussypawsSpraguea umbellataSpraguea umbellata Torr.Spraguea umbellata var. caudiciferaSpraguea umbellata var. caudicifera A. GraySpraguea umbellata var. umbellataumbellate pussypaws

Synopsis

Calyptridium umbellatum (Pussypaws / Mount Hood Pussypaws)

1. Identity and Botanical Classification

Accepted Name, Synonyms, and Nomenclatural History

Calyptridium umbellatum, with accepted synonym Cistanthe umbellata, is a species of flowering plant in the montia family (Montiaceae), known by the common name Mount Hood pussypaws or β€” especially outside the Pacific Northwest β€” simply pussypaws. The genus name reflects the plant's morphology: Calyptridium derives from the Greek word for "veil," referring to the persistent sepals, while the specific epithet umbellatum comes from the Latin word for "sunshade," referring to the shape of the inflorescence.

The nomenclatural history of this species is complex. The currently recognized binomial Calyptridium umbellatum (Torr.) Greene was formally published in the Bulletin of the Torrey Botanical Club (13: 144) in 1886. The species has also passed through an earlier placement as Spraguea umbellata Torr. and is recognized in the Flora of North America as Cistanthe umbellata (Torr.) Hershk. The genus Calyptridium is often included in Cistanthe by some authorities, though the two genera are considered distinct by other workers on the basis of molecular phylogenetics and distributional evidence. Notably, the distribution of Calyptridium is exclusively in western North America, whereas Cistanthe is primarily South American.

Two infraspecific taxa are recognized within the species: Calyptridium umbellatum var. caudiciferum and Calyptridium umbellatum var. umbellatum.

Taxonomic Position

Calyptridium umbellatum belongs to the family Montiaceae within the genus Calyptridium. Montiaceae β€” the miner's lettuce family β€” was segregated from Portulacaceae within approximately the last fifteen years, following molecular and morphological revisions of the order Caryophyllales. Older literature and some taxonomic databases therefore list the genus under Portulacaceae. The genus Calyptridium was historically recognized within the Portulacaceae, alongside such genera as Calandrinia, Cistanthe, Claytonia, Lewisia, Montia, Portulaca, and Talinum.

Common Names

The species is known under several common names, including Cistanthe, Mount Hood Pussypaws, and Pussy Toes. Outside the Pacific Northwest it is frequently referred to simply as "pussypaws." The dense white to pinkish umbel flower clusters are said to resemble the underside of a cat's foot, hence the common name.

2. Botanical Description and Natural Habitat

Morphology

The plant is an annual to perennial, glabrous (hairless), fleshy herb, growing from a much-branched, thickened crown, the branches often numerous, spreading, forming mats up to 15 cm broad. Leaves are all basal, glabrous, tufted, forming rosettes, obovate-spatulate to oblanceolate in shape, and broadly petiolate, reaching 1.5–5 cm in length. Plants produce one or more small, basal rosettes of spatula-shaped leaves from which rise a single, purplish, leafless stem, topped by a dense, spherical cluster of several dozen pinkish-purple flowers.

The small flowers have two round, white or pale pink sepals, four oblong petals, three stamens with yellow or red anthers, and a thread-like style with two stigmas. The flower cluster is between 2 and 3 inches (approximately 5–8 cm) in diameter. Flowering occurs from June through August. The flowering stems of pussypaws will lie flat when it is cold but may lift off the ground during the heat of the day, a behavior that may aid in seed dispersal in warm afternoon wind.

Distribution and Habitat

Calyptridium umbellatum is native to western North America from British Columbia to California and east to Colorado, where it grows in a number of habitat types, including areas inhospitable to many other plant types, such as those with alpine climates. More specifically, it occurs on both sides of the Cascades crest in Washington, and its range extends from British Columbia to Baja California, east to Montana, Wyoming, and Utah.

Pussypaws is a rosette-forming perennial wildflower most often found in montane environments at mid to high elevations, including yellow pine forest, red fir forest, subalpine forest, montane chaparral, alpine fell-fields, and montane meadows and ridgelines. It is often found growing in harsh environments, including open, dry, sandy, or gravelly soils. A small subgroup of C. umbellatum is located in the Zayante Sandhills, a biological island in the Santa Cruz Mountains; these individuals reside on a singular hill in the entirety of the sandhills, and their frail petals and loose seeds allow for easy wind dispersal.

3. Traditional and Historical Use

Indigenous Ethnobotanical Use

Documented traditional use of Calyptridium umbellatum is sparse in the published ethnobotanical literature. The plant has been reported by the Native Americans as an herbal remedy for treating colds, coughs, and sore throats, though the specific tribal affiliations, time period of use, and methods of preparation underlying this claim are not identified in the available secondary sources, and no primary ethnobotanical monograph specifically documenting C. umbellatum use was located during the preparation of this article. At least one naturalist researcher reviewing the species noted that no verifiable ethnobotanical use information could be found. Any attribution of traditional medicinal use to specific tribal cultures must therefore be regarded as unverified pending primary documentation.

Ornamental and Ecological Use

The plant is used in landscape gardening because of its low-growing and attractive pincushion-like appearance, and it has strong potential for use as a rangeland revegetation plant. This is attributed to its ability to grow in disturbed areas, stabilize soil, and prevent erosion. These are ecological applications, not medicinal ones, but they reflect how the plant has been valued in a practical context in the western United States.

4. Phytochemistry and Key Constituents

State of Knowledge

As of the preparation of this article, no peer-reviewed phytochemical analysis of Calyptridium umbellatum itself has been identified in the primary scientific literature indexed in PubMed/MEDLINE, Web of Science, or comparable databases. No pharmacopeial monograph exists for this species, and it is not addressed by the NIH Office of Dietary Supplements, the NCCIH, the European Medicines Agency (EMA), ESCOP, or Commission E. This represents a significant gap in the scientific record.

Inferences from Family-Level Phytochemistry

Given C. umbellatum's placement within the order Caryophyllales and its historical assignment to the Portulacaceae, it is reasonable from a family-level context to note that related genera in this order are characterized by specific classes of secondary metabolites β€” though these have not been verified in C. umbellatum specifically. Betalains are pigments found in approximately 17 families of plants belonging to the order Caryophyllales. Betalains bestow color on flowers of many genera of plants, such as Portulaca. Within the Portulacaceae family, betalains have been reported in the common purslane and related species, though whether Calyptridium umbellatum synthesizes betalains has not been confirmed in published research. The broader Portulacaceae family is also characterized by the potential presence of betalains, saponins, and free oxalate accumulation.

It is critical to emphasize that applying the phytochemical profile of the broader family or order to C. umbellatum would be speculative. No constituent isolation studies, no metabolomics profiling, and no standardized extract characterization of this species are available in the public scientific literature.

5. Scientific Evidence by Area of Use

5.1 Antiparasitic Activity (Schistosomiasis)

The only specific pharmacological evidence identified for Calyptridium umbellatum in the peer-reviewed literature relates to its putative antiparasitic (schistosomicidal) activity. Compounds such as curcumin, artesunate, artemether, as well as avocado and soybean unsaponifiable oils, essential oils from Plectranthus neochilus, and extracts from Calyptridium umbellatum have been noted to cause the separation of males and females of Schistosoma worms. This separation disrupts mating, which is critical to parasite reproduction.

Essential oils from P. neochilus and extracts from Calyptridium umbellatum are postulated to cause separation of females from males (Ndjonka et al., 2013), subsequently disrupting egg production by the parasite and the pathologies associated with egg release within an infected individual. The mated state is a fundamental process of the parasite's viability inside the human host and for establishing the infection.

Strength of evidence: This finding derives from a single citation in a 2013 review article (Ndjonka et al., published in the International Journal of Molecular Sciences), which itself summarizes laboratory-based antiparasitic screening. The original primary study data β€” including the specific extract type, concentration, model organism, and methodology β€” are not detailed in the available secondary sources. No human clinical trials, no controlled animal studies specific to C. umbellatum alone, and no mechanism of action data were identified. The evidence must therefore be classified as extremely preliminary, based on a single citation in a review paper, and is insufficient to support any therapeutic claim.

5.2 Respiratory Conditions (Colds, Coughs, Sore Throats)

As noted under Traditional Use, the plant has been reported as an ethnobotanical remedy for colds, coughs, and sore throats. No scientific study β€” whether in vitro, animal model, or human clinical trial β€” has been identified that examines C. umbellatum for any respiratory indication.

Strength of evidence: No scientific evidence exists. The claim is based solely on an unverified ethnobotanical report.

5.3 Other Areas

No peer-reviewed scientific literature was identified examining Calyptridium umbellatum for any other areas of use, including but not limited to antioxidant activity, anti-inflammatory effects, antimicrobial activity, metabolic conditions, or dermatological applications. The absence of published research in these areas means that no claims in these domains can be substantiated.

6. Body Systems and Health Areas Associated with the Plant

Based strictly on the available evidence:

  • Parasitology / Tropical Infectious Disease: Preliminary in vitro data suggest possible schistosomicidal effects via disruption of parasite mating. Evidence is entirely preclinical and sourced from a single review citation.
  • Respiratory System (Traditional): Unverified traditional use for colds, coughs, and sore throats in an unspecified Native American context. No scientific evidence supports this association.

No other body systems or health areas are associated with this plant in the verifiable scientific or ethnobotanical literature.

7. Dosage Forms and Reported Dosages

Calyptridium umbellatum is not commercially marketed as a standardized dietary supplement. No dosage forms (e.g., capsule, tincture, dried herb, extract) have been described in peer-reviewed literature, pharmacopeial monographs, or regulatory agency guidance documents for this species. No human or animal study dosages are available to report.

The plant's seeds are available from native plant seed suppliers for ecological restoration and ornamental cultivation purposes, but these are not described or sold as dietary supplement ingredients.

8. Safety Considerations

Absence of Formal Safety Data

No toxicology studies, adverse event reports, or safety assessments specific to Calyptridium umbellatum as a consumed substance were identified in the peer-reviewed literature, in FDA adverse event databases, or in the NCCIH or EMA databases. The species is not addressed in any recognized safety reference for botanical dietary supplements.

Family-Level Oxalate Context

Plants in the broader Portulacaceae lineage are noted to often accumulate free oxalates. High oxalate content in related plants such as common purslane (Portulaca oleracea) has been a documented consideration for individuals with certain kidney conditions. Whether C. umbellatum accumulates oxalates at any biologically relevant level has not been studied, and no inference about safety can be reliably drawn from this family-level observation without species-specific data.

Regulatory Status

Calyptridium umbellatum is not recognized as a dietary ingredient by the FDA, is not listed in the NIH Dietary Supplement Label Database, and is not included in any official pharmacopeia (USP, European Pharmacopoeia, or WHO monographs). It has no established Generally Recognized As Safe (GRAS) status. Its status as an ingredient in commercial dietary supplements, if any, would be subject to the New Dietary Ingredient (NDI) notification requirements under the U.S. Dietary Supplement Health and Education Act (DSHEA).

Drug Interactions

No drug interaction data for Calyptridium umbellatum exist in the scientific literature. No interaction studies have been conducted.

9. Summary of Evidence Quality

Calyptridium umbellatum is a well-documented botanical species from a taxonomic and ecological standpoint, native to western North America and described in herbarium records and regional floras. As a dietary supplement or medicinal ingredient, however, it is essentially unstudied. The entirety of its pharmacological evidence consists of a single citation in one review paper suggesting schistosomicidal activity in laboratory screening. No clinical trials in humans have been conducted. No phytochemical characterization has been published. No standardized extracts, dosage forms, or dosage recommendations exist. Its purported traditional use in treating respiratory ailments remains unverified in primary ethnobotanical sources. In every domain relevant to its evaluation as a supplement or natural health ingredient, the evidence base is absent or extremely preliminary. Any health claims made by commercial sources about this plant are not supported by the available scientific literature.

References

Health Conditions

Health conditions that Calyptridium umbellatum may help support.

  • No conditions available.

Body Systems

Body systems that Calyptridium umbellatum may help support.

  • No body systems available.
Join our newsletter

Stay informed. Stay healthy.

Get expert supplement tips, exclusive discounts, and product recommendations delivered to your inbox

Calyptridium umbellatum | Vitabase